Holen Sie sich die Stockscreener-App
138.50
0.51%
0.70
Vorhandelsmarkt:
139.16
0.66
+0.48%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$137.80
Offen:
$137.55
24-Stunden-Volumen:
7.12M
Relative Volume:
0.65
Marktkapitalisierung:
$232.32B
Einnahmen:
$175.96B
Nettoeinkommen (Verlust:
$18.10B
KGV:
14.95
EPS:
9.2638
Netto-Cashflow:
$38.28B
1W Leistung:
+0.26%
1M Leistung:
+2.43%
6M Leistung:
+27.10%
1J Leistung:
+42.53%
1-Tages-Spanne:
$136.57
$138.85
1-Wochen-Bereich:
$133.87
$138.85
52-Wochen-Spanne:
$93.66
$147.96
Citigroup Inc Stock (C) Company Profile
Firmenname
Citigroup Inc
Sektor
Branche
Telefon
(212) 559-1000
Adresse
388 GREENWICH STREET, NEW YORK, NY
Compare C vs JPM, BAC, HSBC, RY, WFC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
C
Citigroup Inc
|
138.50 | 232.32B | 175.96B | 18.10B | 38.28B | 9.2638 |
JPM
Jpmorgan Chase Co
|
353.56 | 939.83B | 297.42B | 64.78B | 148.32B | 23.34 |
BAC
Bank Of America Corp
|
62.56 | 437.47B | 194.43B | 33.77B | 64.54B | 4.3483 |
HSBC
Hsbc Holdings Plc Adr
|
103.70 | 355.15B | 133.80B | 21.76B | 105.99B | 6.0511 |
RY
Royal Bank Of Canada
|
205.98 | 285.16B | 99.69B | 16.04B | 26.84B | 11.15 |
WFC
Wells Fargo Co
|
89.45 | 270.50B | 128.92B | 22.97B | -2.35B | 6.8796 |
Citigroup Inc Stock (C) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-26 | Eingeleitet | Jefferies | Buy |
| 2025-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-05-15 | Eingeleitet | TD Cowen | Hold |
| 2025-01-06 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-12-03 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-04-04 | Bestätigt | Evercore ISI | In-line |
| 2024-03-25 | Bestätigt | Wells Fargo | Overweight |
| 2024-03-14 | Hochstufung | Goldman | Neutral → Buy |
| 2024-02-14 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-30 | Hochstufung | Morgan Stanley | Underweight → Overweight |
| 2024-01-10 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-01-09 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-01-08 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-03 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-18 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-09-07 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-18 | Hochstufung | Odeon | Hold → Buy |
| 2023-07-10 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-12-08 | Eingeleitet | Piper Sandler | Neutral |
| 2022-10-03 | Herabstufung | Goldman | Buy → Neutral |
| 2022-09-06 | Herabstufung | Odeon | Buy → Hold |
| 2022-05-27 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2022-03-28 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-03-07 | Herabstufung | Jefferies | Buy → Hold |
| 2022-03-03 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-03-03 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2021-12-15 | Hochstufung | Odeon | Hold → Buy |
| 2021-12-10 | Fortgesetzt | UBS | Neutral |
| 2021-12-06 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-07 | Fortgesetzt | Keefe Bruyette | Outperform |
| 2021-06-16 | Bestätigt | Credit Suisse | Outperform |
| 2021-04-05 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2021-03-29 | Herabstufung | Edward Jones | Buy → Hold |
| 2021-01-21 | Herabstufung | Berenberg | Buy → Hold |
| 2021-01-06 | Eingeleitet | Daiwa Securities | Buy |
| 2021-01-04 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2020-11-19 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2020-10-15 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-08-18 | Herabstufung | Odeon | Hold → Sell |
| 2020-07-17 | Herabstufung | Odeon | Buy → Hold |
| 2020-07-08 | Eingeleitet | Seaport Global Securities | Buy |
| 2020-07-07 | Hochstufung | Societe Generale | Hold → Buy |
| 2020-06-09 | Herabstufung | Standpoint Research | Buy → Hold |
| 2020-06-02 | Hochstufung | Odeon | Hold → Buy |
| 2020-05-18 | Hochstufung | Standpoint Research | Hold → Buy |
| 2020-04-20 | Hochstufung | Argus | Hold → Buy |
| 2020-04-14 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-04-01 | Herabstufung | Keefe Bruyette | Outperform → Mkt Perform |
| 2020-02-03 | Herabstufung | Odeon | Buy → Hold |
| 2020-01-09 | Eingeleitet | DA Davidson | Buy |
| 2020-01-06 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-01-06 | Bestätigt | Goldman | Buy |
| 2019-07-26 | Hochstufung | Keefe Bruyette | Mkt Perform → Outperform |
| 2019-05-30 | Hochstufung | Goldman | Neutral → Buy |
| 2019-02-22 | Hochstufung | Jefferies | Hold → Buy |
Alle ansehen
Citigroup Inc Aktie (C) Neueste Nachrichten
Citigroup to Launch Blockchain-Based Cross-Border Payments for Japanese Companies - Global Cosmetics News
Citigroup stock heads into the open after a 0.8 percent gain - ad-hoc-news.de
Citigroup (C) Completed a Weekend Tokenized-Dollar Transfer. Can the Network Scale? - Yahoo Finance
SIG Maintained by Citigroup -- Price Target Raised to $140 - GuruFocus
Sana Biotechnology at citigroup’s biopharma back to school summit 2026: diabetes push - Investing.com
BioMarin at Citi summit: voxzogo drives growth as pipeline widens By Investing.com - Investing.com Canada
Olema Oncology at citigroup summit: palazestrant data, delays By Investing.com - Investing.com India
SYK Maintained by Citigroup -- Price Target Lowered to $360 - GuruFocus
Transcript : Novavax, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-10-2026 10 - marketscreener.com
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc. - StreetInsider
Kymera Therapeutics at citigroup summit: oral immunology push gains pace By Investing.com - Investing.com India
SpyGlass Pharma at Citigroup summit: glaucoma lens nears phase iii By Investing.com - Investing.com Canada
SAB BIO at Citi summit: trial progress and a bigger t1d bet - Investing.com India
Jazz Pharmaceuticals at citigroup summit: rare-disease push gains pace By Investing.com - Investing.com India
Roivant at Citi summit: cash-rich biotech leans on three pillars - Investing.com Canada
MercadoLibre Secures $1.0 Billion 5.850% Notes Due 2036 With BofA, Citi, Goldman and Others - TradingView
Form 424B2 CITIGROUP INC - StreetInsider
Acumen at Citi biopharma summit: bets on oligomers and brain delivery - Investing.com
C Pushes Tokenized Deposits Deeper Into Asia With Japan Expansion - TradingView
Citigroup Inc. stock gains as recent earnings beat expectations - ad-hoc-news.de
Why Is Citigroup (NYES:C) Expanding in China Brokerage? - Kalkine Media
Citigroup (C) Gains on Turnaround Momentum - Yahoo Finance
Form 8K Citigroup For: 10 September By Investing.com - Investing.com Canada
Citigroup Adjusts Price Target on Cooper to $60 From $80, Keeps Neutral Rating - marketscreener.com
4 Thriving Investment Bank Behemoths to Buy With Attractive Valuation - TradingView
Citigroup Upgrades UiPath (NYSE:PATH) to "Strong-Buy" - marketbeat.com
Nordnet AB And Citigroup Inc. Launch Research Portal Giving Savers Access To Research - marketscreener.com
Citigroup Inc. $C Shares Acquired by Tidal Investments LLC - marketbeat.com
Citigroup Adjusts Price Target on Boston Scientific to $57 From $61, Keeps Buy Rating - marketscreener.com
Citigroup Adjusts Price Target on ResMed to $240 From $235, Keeps Neutral Rating - marketscreener.com
Citigroup Inc. $C Position Trimmed by National Pension Service - marketbeat.com
WINTON GROUP Ltd Has $11.44 Million Holdings in Citigroup Inc. $C - marketbeat.com
Integrated Wealth Concepts LLC Sells 10,009 Shares of Citigroup Inc. $C - marketbeat.com
Engineers Gate Manager LP Lowers Stake in Citigroup Inc. $C - marketbeat.com
BlueCrest Capital Management Ltd Reduces Holdings in Citigroup Inc. $C - marketbeat.com
Citigroup stock heads into the open after a 1.0 percent gain - ad-hoc-news.de
Citigroup Becomes Substantial Shareholder in Lotus Resources with 5.08% Stake - Kalkine
BioAge at Citi biopharma summit: pivot to eye disease and new targets - Investing.com Canada
Citigroup's Private Bank Hires Radzinski From Bank Of America - marketscreener.com
Veradermics at citigroup summit: oral hair-loss drug nears key data - Investing.com
Citi Private Bank hires Radzinski from Bank of America - WTVB
Akamai Technologies Jumps 5.3% After Citigroup Maintains Neutral - AlphaStreet
Transcript : Cytokinetics, Incorporated Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 03:00 PM - marketscreener.com
Beam Therapeutics at Citi summit: platform gains momentum across pipeline By Investing.com - Investing.com Canada
Citigroup : Citi First Quarter, Second Quarter, Third Quarter and Fourth Quarter 2027 Earnings Calls - marketscreener.com
RHP Maintained by Citigroup -- Price Target Raised to $135 - GuruFocus
Cytokinetics at citigroup summit: hcm expansion drives growth hopes By Investing.com - Investing.com India
Transcript : Protagonist Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Transcript : Beam Therapeutics Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 01 - marketscreener.com
Lexicon Pharmaceuticals at Citi summit: hcm data, t1d reset - Investing.com
Transcript : Spyre Therapeutics, Inc. Presents at Citigroup?s Biopharma Back to School Summit 2026, Sep-09-2026 10 - marketscreener.com
Finanzdaten der Citigroup Inc-Aktie (C)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):